...Health info at your doorstep

Pharmamax Plans Huge Investment in Cardiovascular Therapies

Pharmamax Plans Huge Investment in Cardiovascular Therapies

Pharmamax Nigeria Limited, an emerging pharmaceutical generic marketing company in Nigeria, plans to invest in broad range of cardiovascular remedies before the end of the year to enhance patient’s accessibility to anti-hypertensive medicines.

The company is spurred by encouragements it received from numerous physicians and drugstores across the country on account of efficacy of its Pharmamax brands of Amlodipine and Lisinopril therapies in restoring health and saving lives of patients across the country.

‘’The testimonies we are getting especially from physicians in major hospitals across the country on Pharmamax Amlodipine and Lisinopril is encouraging and provide insight into what we need to do next,’’ Morgan Nwanguma, Head Public Communication and New Media in KCH Group said recently in Lagos.

In a related development, the company intends to institute annual Pharmamax Cardiovascular Academic Awards in the faculty of pharmaceutical sciences in select Nigerian universities next year. The company will partner with authorities of the select universities and reward winners of the award and their Dean of Faculty with mouth- watering cash prizes.

 

Comment Here

Leave a Reply

Your email address will not be published.